Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
Titel:
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
Auteur:
Kim, Paul Sanchez, Ana M Penke, Taylor J R Tuson, Hannah H Kime, James C McKee, Robert W Slone, William L Conley, Nicholas R McMillan, Lana J Prybol, Cameron J Garofolo, Paul M